Literature DB >> 15217804

Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease.

Eleanor M Scott1, Robert A S Ariëns, Peter J Grant.   

Abstract

The formation of a fibrin clot is one of the key events in atherothrombotic vascular disease. The structure of the fibrin clot and the genetic and environmental factors that modify it have effects on its biological function. Alterations in fibrin structure and function have implications for the clinical presentation of vascular disease. This review briefly describes the key features involved in the formation of a fibrin clot, its typical structure, and function. This is followed by a review of the current literature on genetic and environmental influences on fibrin structure/function and the relationship to clinical disease. The formation of a fibrin clot is one of the key events in atherothrombotic vascular disease. This review discusses how genetic and environmental factors alter fibrin structure and function and the implications this has for the clinical presentation of vascular disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15217804     DOI: 10.1161/01.ATV.0000136649.83297.bf

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  23 in total

1.  Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Authors:  James R Cerhan; Stephen M Ansell; Zachary S Fredericksen; Neil E Kay; Mark Liebow; Timothy G Call; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Wen Liu-Mares; William R Macon; Diane Jelinek; Thomas E Witzig; Thomas M Habermann; Susan L Slager
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

Review 2.  Evaluation of corneal cell growth on tissue engineering materials as artificial cornea scaffolds.

Authors:  Hai-Yan Wang; Rui-Hua Wei; Shao-Zhen Zhao
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

3.  Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population.

Authors:  Elena V Zholdybayeva; Yerkebulan A Talzhanov; Akbota M Aitkulova; Pavel V Tarlykov; Gulmira N Kulmambetova; Aisha N Iskakova; Aliya U Dzholdasbekova; Olga A Visternichan; Dana Zh Taizhanova; Yerlan M Ramanculov
Journal:  Hum Genomics       Date:  2016-06-08       Impact factor: 4.639

4.  Effect of blood microparticles on the kinetics of polymerization and enzymatic hydrolysis of fibrin.

Authors:  R M Nabiullina; I G Mustafin; Y F Zuev; D A Faizullin; R I Litvinov; L D Zubairova
Journal:  Dokl Biochem Biophys       Date:  2015-07-12       Impact factor: 0.788

5.  FXIII-A Leu34 genetic variant in premature coronary artery disease: a genotype--phenotype case control study.

Authors:  Johanne Silvain; Ana Pena; Jean-Baptiste Vignalou; Jean-Sébastien Hulot; Sophie Galier; Guillaume Cayla; Anne Bellemain-Appaix; Olivier Barthélémy; Farzin Beygui; Claire Bal-dit-Sollier; Ludovic Drouet; John W Weisel; Gilles Montalescot; Jean-Phillippe Collet
Journal:  Thromb Haemost       Date:  2011-07-28       Impact factor: 5.249

Review 6.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

7.  Fibrin architecture in clots: a quantitative polarized light microscopy analysis.

Authors:  Peter Whittaker; Karin Przyklenk
Journal:  Blood Cells Mol Dis       Date:  2008-12-02       Impact factor: 3.039

8.  Architecture of intraluminal thrombus removed from abdominal aortic aneurysm.

Authors:  Paweł Matusik; Piotr Mazur; Ewa Stepień; Roman Pfitzner; Jerzy Sadowski; Anetta Undas
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

9.  Why dysfibrinogenaemias still matter.

Authors:  John W Weisel
Journal:  Thromb Haemost       Date:  2009-09       Impact factor: 5.249

10.  High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; Marisa M Magaña; Ni-Cheng Liang; Xavier Soler; Daniel J Desantis; Debby Ngo; Virgil L Woods
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.